表紙
市場調查報告書

患者腫瘤組織移植 (PDX) 模式的全球市場

Patient Derived Xenograft/PDX Models

出版商 Global Industry Analysts, Inc. 商品編碼 913474
出版日期 內容資訊 英文 164 Pages
商品交期: 最快1-2個工作天內
價格
患者腫瘤組織移植 (PDX) 模式的全球市場 Patient Derived Xenograft/PDX Models
出版日期: 2020年07月01日內容資訊: 英文 164 Pages
簡介

本報告提供全球患者腫瘤組織移植 (PDX) 模式市場概要,彙整趨勢·發展的影響因素分析,競爭企業與市場佔有率,世界及各地區·各主要國家的市場規模的變化與預測,主要企業簡介等資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球市場的企業佔有率
    • 全球患者腫瘤組織移植 (PDX) 模式市場上企業佔有率方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 加拿大
    • 日本
    • 中國
    • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 其他歐洲
    • 亞太地區
    • 其他地區

第4章 競爭企業

  • CHAMPIONS ONCOLOGY
  • CHARLES RIVER LABORATORIES INTERNATIONAL
  • CROWN BIOSCIENCE
  • EPO BERLIN-BUCH GMBH
  • HERA BIOLABS
  • ONCODESIGN
  • PHARMATEST SERVICES LTD.
  • THE JACKSON LABORATORY
  • UROLEAD SAS
  • WUXI APPTEC
  • XENTECH

第5章 調查資料

目錄
Product Code: MCP13873

Global Patient Derived Xenograft/PDX Models Market to Reach $294.7 Million by 2027

Amid the COVID-19 crisis, the global market for Patient Derived Xenograft/PDX Models estimated at US$102.7 Million in the year 2020, is projected to reach a revised size of US$294.7 Million by 2027, growing at aCAGR of 16.3% over the period 2020-2027. Mouse, one of the segments analyzed in the report, is projected to record 15.3% CAGR and reach US$197.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Rat segment is readjusted to a revised 18.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $30.4 Million, While China is Forecast to Grow at 15.7% CAGR

The Patient Derived Xenograft/PDX Models market in the U.S. is estimated at US$30.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$51.2 Million by the year 2027 trailing a CAGR of 15.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.5% and 14% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 11.9% CAGR.We bring years of research experience to this 7th edition of our report. The 164-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Champions Oncology, Inc.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc.
  • Epo Berlin-Buch GmbH
  • Hera BioLabs
  • Oncodesign
  • Pharmatest Services Ltd.
  • The Jackson Laboratory
  • Urolead SAS
  • WuXi AppTec
  • Xentech

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Patient Derived Xenograft/PDX Models Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Patient Derived Xenograft/PDX Models Global Market Estimates and Forecasts in US$ by Region/Country: 2020-2027
  • TABLE 2: Patient Derived Xenograft/PDX Models Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
  • TABLE 3: Mouse (Type) World Market by Region/Country in US$: 2020 to 2027
  • TABLE 4: Mouse (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
  • TABLE 5: Rat (Type) Potential Growth Markets Worldwide in US$: 2020 to 2027
  • TABLE 6: Rat (Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
  • TABLE 7: Pre-Clinical Drug Development (Application) Global Market Estimates & Forecasts in US$ by Region/Country: 2020-2027
  • TABLE 8: Pre-Clinical Drug Development (Application) Market Share Breakdown by Region/Country: 2020 VS 2027
  • TABLE 9: Basic Cancer Research (Application) Demand Potential Worldwide in US$ by Region/Country: 2020-2027
  • TABLE 10: Basic Cancer Research (Application) Share Breakdown Review by Region/Country: 2020 VS 2027
  • TABLE 11: Pharma & Biotech (End-Use) Worldwide Latent Demand Forecasts in US$ by Region/Country: 2020-2027
  • TABLE 12: Pharma & Biotech (End-Use) Distribution of Global Sales by Region/Country: 2020 VS 2027
  • TABLE 13: CRO (End-Use) Sales Estimates and Forecasts in US$ by Region/Country for the Years 2020 through 2027
  • TABLE 14: CRO (End-Use) Global Market Share Distribution by Region/Country for 2020 and 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Patient Derived Xenograft/PDX Models Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 15: United States Patient Derived Xenograft/PDX Models Market Estimates and Projections in US$ by Type: 2020 to 2027
    • TABLE 16: United States Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2020 VS 2027
    • TABLE 17: United States Patient Derived Xenograft/PDX Models Latent Demand Forecasts in US$ by Application: 2020 to 2027
    • TABLE 18: Patient Derived Xenograft/PDX Models Market Share Breakdown in the United States by Application: 2020 VS 2027
    • TABLE 19: United States Patient Derived Xenograft/PDX Models Latent Demand Forecasts in US$ by End-Use: 2020 to 2027
    • TABLE 20: Patient Derived Xenograft/PDX Models Market Share Breakdown in the United States by End-Use: 2020 VS 2027
  • CANADA
    • TABLE 21: Canadian Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2020 to 2027
    • TABLE 22: Patient Derived Xenograft/PDX Models Market in Canada: Percentage Share Breakdown of Sales by Type for 2020 and 2027
    • TABLE 23: Canadian Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by Application: 2020 to 2027
    • TABLE 24: Canadian Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2020 VS 2027
    • TABLE 25: Canadian Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by End-Use: 2020 to 2027
    • TABLE 26: Canadian Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2020 VS 2027
  • JAPAN
    • TABLE 27: Japanese Market for Patient Derived Xenograft/PDX Models: Annual Sales Estimates and Projections in US$ by Type for the Period 2020-2027
    • TABLE 28: Japanese Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2020 VS 2027
    • TABLE 29: Japanese Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by Application: 2020 to 2027
    • TABLE 30: Patient Derived Xenograft/PDX Models Market Share Shift in Japan by Application: 2020 VS 2027
    • TABLE 31: Japanese Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2020 to 2027
    • TABLE 32: Patient Derived Xenograft/PDX Models Market Share Shift in Japan by End-Use: 2020 VS 2027
  • CHINA
    • TABLE 33: Chinese Patient Derived Xenograft/PDX Models Market Growth Prospects in US$ by Type for the Period 2020-2027
    • TABLE 34: Chinese Patient Derived Xenograft/PDX Models Market by Type: Percentage Breakdown of Sales for 2020 and 2027
    • TABLE 35: Chinese Demand for Patient Derived Xenograft/PDX Models in US$ by Application: 2020 to 2027
    • TABLE 36: Chinese Patient Derived Xenograft/PDX Models Market Share Breakdown by Application: 2020 VS 2027
    • TABLE 37: Chinese Demand for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2020 to 2027
    • TABLE 38: Chinese Patient Derived Xenograft/PDX Models Market Share Breakdown by End-Use: 2020 VS 2027
  • EUROPE
    • Market Facts & Figures
    • European Patient Derived Xenograft/PDX Models Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Market Analytics
    • TABLE 39: European Patient Derived Xenograft/PDX Models Market Demand Scenario in US$ by Region/Country: 2018-2025
    • TABLE 40: European Patient Derived Xenograft/PDX Models Market Share Shift by Region/Country: 2020 VS 2027
    • TABLE 41: European Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2020-2027
    • TABLE 42: European Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2020 VS 2027
    • TABLE 43: European Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by Application: 2020-2027
    • TABLE 44: European Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2020 VS 2027
    • TABLE 45: European Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by End-Use: 2020-2027
    • TABLE 46: European Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2020 VS 2027
  • FRANCE
    • TABLE 47: Patient Derived Xenograft/PDX Models Market in France by Type: Estimates and Projections in US$ for the Period 2020-2027
    • TABLE 48: French Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2020 VS 2027
    • TABLE 49: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in France in US$ by Application: 2020-2027
    • TABLE 50: French Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
    • TABLE 51: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in France in US$ by End-Use: 2020-2027
    • TABLE 52: French Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
  • GERMANY
    • TABLE 53: Patient Derived Xenograft/PDX Models Market in Germany: Recent Past, Current and Future Analysis in US$ by Type for the Period 2020-2027
    • TABLE 54: German Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2020 VS 2027
    • TABLE 55: Patient Derived Xenograft/PDX Models Market in Germany: Annual Sales Estimates and Forecasts in US$ by Application for the Period 2020-2027
    • TABLE 56: Patient Derived Xenograft/PDX Models Market Share Distribution in Germany by Application: 2020 VS 2027
    • TABLE 57: Patient Derived Xenograft/PDX Models Market in Germany: Annual Sales Estimates and Forecasts in US$ by End-Use for the Period 2020-2027
    • TABLE 58: Patient Derived Xenograft/PDX Models Market Share Distribution in Germany by End-Use: 2020 VS 2027
  • ITALY
    • TABLE 59: Italian Patient Derived Xenograft/PDX Models Market Growth Prospects in US$ by Type for the Period 2020-2027
    • TABLE 60: Italian Patient Derived Xenograft/PDX Models Market by Type: Percentage Breakdown of Sales for 2020 and 2027
    • TABLE 61: Italian Demand for Patient Derived Xenograft/PDX Models in US$ by Application: 2020 to 2027
    • TABLE 62: Italian Patient Derived Xenograft/PDX Models Market Share Breakdown by Application: 2020 VS 2027
    • TABLE 63: Italian Demand for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2020 to 2027
    • TABLE 64: Italian Patient Derived Xenograft/PDX Models Market Share Breakdown by End-Use: 2020 VS 2027
  • UNITED KINGDOM
    • TABLE 65: United Kingdom Market for Patient Derived Xenograft/PDX Models: Annual Sales Estimates and Projections in US$ by Type for the Period 2020-2027
    • TABLE 66: United Kingdom Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2020 VS 2027
    • TABLE 67: United Kingdom Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by Application: 2020 to 2027
    • TABLE 68: Patient Derived Xenograft/PDX Models Market Share Shift in the United Kingdom by Application: 2020 VS 2027
    • TABLE 69: United Kingdom Demand Estimates and Forecasts for Patient Derived Xenograft/PDX Models in US$ by End-Use: 2020 to 2027
    • TABLE 70: Patient Derived Xenograft/PDX Models Market Share Shift in the United Kingdom by End-Use: 2020 VS 2027
  • REST OF EUROPE
    • TABLE 71: Rest of Europe Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2020-2027
    • TABLE 72: Rest of Europe Patient Derived Xenograft/PDX Models Market Share Breakdown by Type: 2020 VS 2027
    • TABLE 73: Rest of Europe Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by Application: 2020-2027
    • TABLE 74: Rest of Europe Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2020 VS 2027
    • TABLE 75: Rest of Europe Patient Derived Xenograft/PDX Models Addressable Market Opportunity in US$ by End-Use: 2020-2027
    • TABLE 76: Rest of Europe Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 77: Patient Derived Xenograft/PDX Models Market in Asia-Pacific by Type: Estimates and Projections in US$ for the Period 2020-2027
    • TABLE 78: Asia-Pacific Patient Derived Xenograft/PDX Models Market Share Analysis by Type: 2020 VS 2027
    • TABLE 79: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in Asia-Pacific in US$ by Application: 2020-2027
    • TABLE 80: Asia-Pacific Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
    • TABLE 81: Patient Derived Xenograft/PDX Models Quantitative Demand Analysis in Asia-Pacific in US$ by End-Use: 2020-2027
    • TABLE 82: Asia-Pacific Patient Derived Xenograft/PDX Models Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
  • REST OF WORLD
    • TABLE 83: Rest of World Patient Derived Xenograft/PDX Models Market Estimates and Forecasts in US$ by Type: 2020 to 2027
    • TABLE 84: Patient Derived Xenograft/PDX Models Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2020 and 2027
    • TABLE 85: Rest of World Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by Application: 2020 to 2027
    • TABLE 86: Rest of World Patient Derived Xenograft/PDX Models Market Share Analysis by Application: 2020 VS 2027
    • TABLE 87: Rest of World Patient Derived Xenograft/PDX Models Market Quantitative Demand Analysis in US$ by End-Use: 2020 to 2027
    • TABLE 88: Rest of World Patient Derived Xenograft/PDX Models Market Share Analysis by End-Use: 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 38